English
Unichem Laboratories Q2 Results
- BSE: 506690
- NSE: UNICHEMLAB
- ISIN: INE351A01035
- Sector: Major Drugs
BSE
459.10
-2.75 (-0.60%)
-2.75 (-0.60%)Volume205.00
Updated: Fri 12 Dec, 2025 | 10:10:26
NSE
460.15-4.90 (-1.05%)
-4.90 (-1.05%)Volume776.00
Updated: Fri 12 Dec, 2025 | 09:58:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹578.96 Cr.(14.11%)
- Operating Profit₹-23.55 Cr.(NA%)
- Profit After Tax₹-11.89 Cr.(NA%)
- Operating Margin-4.07%(NA%)
Note: Comparison is on YoY basis
Quarterly - Unichem Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 602.51 | 535.90 | 12.43% | 484.13 | 24.45% |
| Depreciation/ Amortization | 31.47 | 31.79 | -1.01% | 32.26 | -2.45% |
| Operating Income | -23.55 | -9.30 | 153.23% | 23.23 | 0.00% |
| Net Income | -11.89 | -10.47 | 13.56% | 24.63 | 0.00% |
| Other Operating Expenses Total | 142.27 | 151.64 | -6.18% | 135.21 | 5.22% |
| Net Income Before Taxes | -10.82 | -9.02 | 19.96% | 27.13 | 0.00% |
| Total Revenue | 578.96 | 526.60 | 9.94% | 507.36 | 14.11% |
| Selling/ General/ Admin Expenses Total | 100.13 | 107.42 | -6.79% | 101.86 | -1.70% |
| Diluted Normalized EPS | 3.69 | -1.49 | 0.00% | 3.49 | 5.80% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.